ATI The Cardiovascular System Test
Questions & Answers 2026-2027 |
100% Correct (Rationales)
Document Overview
This document provides 25 verified questions with 100% correct answers and detailed
rationales on the cardiovascular system. It is suitable for students to study, review
material, and prepare for certification exams by understanding key concepts and their
explanations.
100% Accurate Questions and Answers 100% Guarantee Pass - Verified by Experts
Expert-Verified
Verified Answers · Detailed Rationales · 25 Questions · September 2026
ATI The Cardiovascular System Test Questions & Answers 2026-2027 | 100% Correct (Rationales) - Practice Questions Page 0
, Topics Covered
Section 1: Heart Failure & Antiarrhythmic Agents Q 1-5
Questions covering heart Failure & Antiarrhythmic Agents concepts.
Section 2: Antihypertensive Medications Q 6-11
Questions covering antihypertensive Medications concepts.
Section 3: Cardiac Dysrhythmia Medications Q 12-16
Questions covering cardiac Dysrhythmia Medications concepts.
Section 4: Lipid-Lowering Agents & Angina Q 17-21
Questions covering lipid-Lowering Agents & Angina concepts.
Section 5: Diuretics & Electrolyte Balance Q 22-25
Questions covering diuretics & Electrolyte Balance concepts.
Questions
QUESTION 1 OF 25
A nurse is reviewing new prescriptions with a client who has heart disease. The nurse
should instruct the client that which of the following drugs is prescribed to treat
hypercholesterolemia?
A. Simvastatin
B. Furosemide
C. Losartan
D. Nitroglycerin
Correct Answer: A. Simvastatin
Rationale: Simvastatin is a statin medication that inhibits HMG-CoA reductase, the rate-limiting enzyme in
cholesterol synthesis. By reducing cholesterol production in the liver, simvastatin effectively lowers serum cholesterol
levels, making it the prescribed treatment for hypercholesterolemia. Furosemide is a loop diuretic, losartan is an
angiotensin II receptor blocker, and nitroglycerin is a vasodilator, none of which primarily target
hypercholesterolemia. This aligns with A. Simvastatin.
QUESTION 2 OF 25
A nurse should recognize that milrinone is contraindicated for a client who has which
of the following conditions?
A. Acute myocardial infarction
B. Peripheral vascular disease
C. Ulcerative colitis
D. Ventricular tachycardia
Correct Answer: A. Acute myocardial infarction
Rationale: Milrinone is a phosphodiesterase-3 inhibitor that increases cardiac contractility and causes vasodilation.
In acute myocardial infarction, increasing myocardial oxygen demand through positive inotropy can worsen ischemia
and myocardial damage. Therefore, milrinone is contraindicated in acute myocardial infarction due to the risk of
exacerbating myocardial injury. This aligns with A. Acute myocardial infarction and Acute myocardial infarction.
ATI The Cardiovascular System Test Questions & Answers 2026-2027 | 100% Correct (Rationales) - Practice Questions Page 0